Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04744935 · ClinicalTrials.gov registry record · NA
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
A NA study of Basal Cell Carcinoma and Superficial Basal Cell Carcinoma, sponsored by Christopher Zachary.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04744935 is a NA study of Basal Cell Carcinoma and Superficial Basal Cell Carcinoma that is actively recruiting participants, run by Christopher Zachary. The registered enrollment target is 40 participants, below the 103-participant average among 24 other Basal Cell Carcinoma trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04744935, a NA study of Basal Cell Carcinoma and Superficial Basal Cell Carcinoma, is actively recruiting participants, sponsored by Christopher Zachary.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Optical coherence tomography guided laser treatment of basal cell carcinoma
Conditions Studied
Interventions
- DEVICE 1064 nm long-pulse Nd:YAG laser
Study Locations (1)
California
- UCI Health Gottschalk Medical Plaza - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-01-13 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04744935
The ClinicalTrials.gov registry entry for NCT04744935 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 24 other Basal Cell Carcinoma trials with a reported enrollment target (61% lower). The listed sponsor is Christopher Zachary, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Basal Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which 1064 nm long-pulse Nd:YAG laser is the first listed.
NCT04744935 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04744935 about?
NCT04744935 is a clinical study titled "Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma". Optical coherence tomography guided laser treatment of basal cell carcinoma
What is the current status of trial NCT04744935?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-01-13. Estimated completion is 2025-12-31.
What conditions does trial NCT04744935 study?
This clinical trial studies the following conditions: Basal Cell Carcinoma, Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma.
What interventions are being tested in trial NCT04744935?
The interventions under investigation include: 1064 nm long-pulse Nd:YAG laser (DEVICE).
Who is sponsoring clinical trial NCT04744935?
This trial is sponsored by Christopher Zachary, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04744935 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Basal Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
RECRUITING · NA
-
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
RECRUITING · NA
-
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
COMPLETED · NA
-
Video-Based Treatment Options for Basal Cell Carcinoma
COMPLETED · NA
-
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
RECRUITING · Phase 2
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.